Department Stores
Compare Stocks
4 / 10Stock Comparison
M vs DDS vs KSS vs BKE
Revenue, margins, valuation, and 5-year total return — side by side.
Department Stores
Department Stores
Apparel - Retail
M vs DDS vs KSS vs BKE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Department Stores | Department Stores | Department Stores | Apparel - Retail |
| Market Cap | $5.35B | $6.67B | $1.60B | $2.72B |
| Revenue (TTM) | $22.62B | $6.56B | $15.53B | $1.28B |
| Net Income (TTM) | $642M | $571M | $271M | $206M |
| Gross Margin | 36.5% | 38.3% | 36.1% | 48.9% |
| Operating Margin | 4.6% | 10.5% | 3.3% | 20.1% |
| Forward P/E | 9.1x | 16.9x | 10.3x | 13.4x |
| Total Debt | $5.20B | $358M | $2.45B | $326M |
| Cash & Equiv. | $1.25B | $862M | $674M | $267M |
M vs DDS vs KSS vs BKE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Macy's, Inc. (M) | 100 | 311.6 | +211.6% |
| Dillard's, Inc. (DDS) | 100 | 1904.3 | +1804.3% |
| Kohl's Corporation (KSS) | 100 | 75.0 | -25.0% |
| The Buckle, Inc. (BKE) | 100 | 387.4 | +287.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: M vs DDS vs KSS vs BKE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
M is the clearest fit if your priority is value.
- Lower P/E (9.1x vs 13.4x)
DDS is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 12 yrs, beta 1.15, yield 5.6%
- Rev growth -0.4%, EPS growth -1.0%, 3Y rev CAGR -2.1%
- 9.0% 10Y total return vs BKE's 221.3%
- Lower volatility, beta 1.15, Low D/E 15.2%, current ratio 2.65x
KSS is the clearest fit if your priority is momentum.
- +108.8% vs BKE's +62.7%
BKE carries the broadest edge in this set and is the clearest fit for defensive.
- Beta 0.89, yield 7.3%, current ratio 2.05x
- 16.1% margin vs KSS's 1.7%
- Beta 0.89 vs KSS's 2.32
- 20.6% ROA vs KSS's 2.0%, ROIC 38.4% vs 4.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | -0.4% revenue growth vs KSS's -4.3% | |
| Value | Lower P/E (9.1x vs 13.4x) | |
| Quality / Margins | 16.1% margin vs KSS's 1.7% | |
| Stability / Safety | Beta 0.89 vs KSS's 2.32 | |
| Dividends | 5.6% yield, 12-year raise streak, vs BKE's 7.3% | |
| Momentum (1Y) | +108.8% vs BKE's +62.7% | |
| Efficiency (ROA) | 20.6% ROA vs KSS's 2.0%, ROIC 38.4% vs 4.6% |
M vs DDS vs KSS vs BKE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
M vs DDS vs KSS vs BKE — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BKE leads in 3 of 6 categories
KSS leads 1 • DDS leads 1 • M leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BKE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
M is the larger business by revenue, generating $22.6B annually — 17.7x BKE's $1.3B. BKE is the more profitable business, keeping 16.1% of every revenue dollar as net income compared to KSS's 1.7%. On growth, BKE holds the edge at +9.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $22.6B | $6.6B | $15.5B | $1.3B |
| EBITDAEarnings before interest/tax | $1.9B | $868M | $1.2B | $282M |
| Net IncomeAfter-tax profit | $642M | $571M | $271M | $206M |
| Free Cash FlowCash after capex | $1.1B | $620M | $1.2B | $215M |
| Gross MarginGross profit ÷ Revenue | +36.5% | +38.3% | +36.1% | +48.9% |
| Operating MarginEBIT ÷ Revenue | +4.6% | +10.5% | +3.3% | +20.1% |
| Net MarginNet income ÷ Revenue | +2.8% | +8.7% | +1.7% | +16.1% |
| FCF MarginFCF ÷ Revenue | +4.7% | +9.5% | +7.5% | +16.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -1.1% | -3.0% | -4.2% | +9.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +51.2% | -3.1% | +153.5% | +9.1% |
Valuation Metrics
KSS leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
At 6.0x trailing earnings, KSS trades at a 61% valuation discount to DDS's 15.3x P/E. On an enterprise value basis, KSS's 2.8x EV/EBITDA is more attractive than BKE's 10.6x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $5.4B | $6.7B | $1.6B | $2.7B |
| Enterprise ValueMkt cap + debt − cash | $9.3B | $6.2B | $3.4B | $2.8B |
| Trailing P/EPrice ÷ TTM EPS | 8.31x | 15.35x | 6.01x | 13.78x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.06x | 16.85x | 10.30x | 13.41x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | 1.09x |
| EV / EBITDAEnterprise value multiple | 4.84x | 7.10x | 2.79x | 10.56x |
| Price / SalesMarket cap ÷ Revenue | 0.24x | 1.02x | 0.10x | 2.24x |
| Price / BookPrice ÷ Book value/share | 1.10x | 3.71x | 0.40x | 6.36x |
| Price / FCFMarket cap ÷ FCF | 5.07x | 10.69x | 1.45x | 13.63x |
Profitability & Efficiency
BKE leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
BKE delivers a 44.4% return on equity — every $100 of shareholder capital generates $44 in annual profit, vs $7 for KSS. DDS carries lower financial leverage with a 0.15x debt-to-equity ratio, signaling a more conservative balance sheet compared to M's 1.07x. On the Piotroski fundamental quality scale (0–9), M scores 7/9 vs BKE's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +14.2% | +24.3% | +6.9% | +44.4% |
| ROA (TTM)Return on assets | +4.0% | +16.3% | +2.0% | +20.6% |
| ROICReturn on invested capital | +8.7% | +29.7% | +4.6% | +38.4% |
| ROCEReturn on capital employed | +8.7% | +26.0% | +4.8% | +35.3% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 6 | 7 | 4 |
| Debt / EquityFinancial leverage | 1.07x | 0.15x | 0.61x | 0.77x |
| Net DebtTotal debt minus cash | $4.0B | -$504M | $1.8B | $59M |
| Cash & Equiv.Liquid assets | $1.2B | $862M | $674M | $267M |
| Total DebtShort + long-term debt | $5.2B | $358M | $2.5B | $326M |
| Interest CoverageEBIT ÷ Interest expense | 10.62x | — | 2.17x | — |
Total Returns (Dividends Reinvested)
DDS leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in DDS five years ago would be worth $63,939 today (with dividends reinvested), compared to $3,572 for KSS. Over the past 12 months, KSS leads with a +108.8% total return vs BKE's +62.7%. The 3-year compound annual growth rate (CAGR) favors DDS at 29.0% vs KSS's -4.1% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -14.4% | -12.2% | -32.7% | +6.4% |
| 1-Year ReturnPast 12 months | +69.1% | +67.0% | +108.8% | +62.7% |
| 3-Year ReturnCumulative with dividends | +39.2% | +114.6% | -11.7% | +95.0% |
| 5-Year ReturnCumulative with dividends | +29.2% | +539.4% | -64.3% | +77.3% |
| 10-Year ReturnCumulative with dividends | -24.7% | +899.7% | -24.7% | +221.3% |
| CAGR (3Y)Annualised 3-year return | +11.7% | +29.0% | -4.1% | +24.9% |
Risk & Volatility
BKE leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
BKE is the less volatile stock with a 0.89 beta — it tends to amplify market swings less than KSS's 2.32 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. BKE currently trades 86.9% from its 52-week high vs KSS's 56.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.42x | 1.15x | 2.32x | 0.89x |
| 52-Week HighHighest price in past year | $24.41 | $741.98 | $25.22 | $61.69 |
| 52-Week LowLowest price in past year | $10.54 | $343.12 | $6.47 | $34.95 |
| % of 52W HighCurrent price vs 52-week peak | +79.0% | +75.4% | +56.5% | +86.9% |
| RSI (14)Momentum oscillator 0–100 | 47.6 | 35.2 | 48.6 | 45.5 |
| Avg Volume (50D)Average daily shares traded | 6.7M | 106K | 4.6M | 393K |
Analyst Outlook
Evenly matched — DDS and BKE each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: M as "Hold", DDS as "Hold", KSS as "Hold", BKE as "Hold". Consensus price targets imply 26.4% upside for KSS (target: $18) vs -1.1% for BKE (target: $53). For income investors, BKE offers the higher dividend yield at 7.34% vs KSS's 3.42%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Hold | Hold | Hold |
| Price TargetConsensus 12-month target | $19.20 | $555.00 | $18.00 | $53.00 |
| # AnalystsCovering analysts | 40 | 13 | 39 | 20 |
| Dividend YieldAnnual dividend ÷ price | +3.7% | +5.6% | +3.4% | +7.3% |
| Dividend StreakConsecutive years of raises | 4 | 12 | 0 | 0 |
| Dividend / ShareAnnual DPS | $0.71 | $31.08 | $0.49 | $3.94 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.7% | 0.0% | 0.0% | 0.0% |
BKE leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). KSS leads in 1 (Valuation Metrics). 1 tied.
M vs DDS vs KSS vs BKE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is M or DDS or KSS or BKE a better buy right now?
For growth investors, Dillard's, Inc.
(DDS) is the stronger pick with -0. 4% revenue growth year-over-year, versus -4. 3% for Kohl's Corporation (KSS). Kohl's Corporation (KSS) offers the better valuation at 6. 0x trailing P/E (10. 3x forward), making it the more compelling value choice. Analysts rate Macy's, Inc. (M) a "Hold" — based on 40 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — M or DDS or KSS or BKE?
On trailing P/E, Kohl's Corporation (KSS) is the cheapest at 6.
0x versus Dillard's, Inc. at 15. 3x. On forward P/E, Macy's, Inc. is actually cheaper at 9. 1x — notably different from the trailing picture, reflecting expected earnings growth.
03Which is the better long-term investment — M or DDS or KSS or BKE?
Over the past 5 years, Dillard's, Inc.
(DDS) delivered a total return of +539. 4%, compared to -64. 3% for Kohl's Corporation (KSS). Over 10 years, the gap is even starker: DDS returned +918. 4% versus KSS's -23. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — M or DDS or KSS or BKE?
By beta (market sensitivity over 5 years), The Buckle, Inc.
(BKE) is the lower-risk stock at 0. 89β versus Kohl's Corporation's 2. 32β — meaning KSS is approximately 159% more volatile than BKE relative to the S&P 500. On balance sheet safety, Dillard's, Inc. (DDS) carries a lower debt/equity ratio of 15% versus 107% for Macy's, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — M or DDS or KSS or BKE?
By revenue growth (latest reported year), Dillard's, Inc.
(DDS) is pulling ahead at -0. 4% versus -4. 3% for Kohl's Corporation (KSS). On earnings-per-share growth, the picture is similar: Kohl's Corporation grew EPS 144. 3% year-over-year, compared to -11. 6% for The Buckle, Inc.. Over a 3-year CAGR, BKE leads at -2. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — M or DDS or KSS or BKE?
The Buckle, Inc.
(BKE) is the more profitable company, earning 16. 1% net margin versus 1. 8% for Kohl's Corporation — meaning it keeps 16. 1% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BKE leads at 19. 8% versus 3. 3% for KSS. At the gross margin level — before operating expenses — BKE leads at 48. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is M or DDS or KSS or BKE more undervalued right now?
On forward earnings alone, Macy's, Inc.
(M) trades at 9. 1x forward P/E versus 16. 9x for Dillard's, Inc. — 7. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KSS: 26. 4% to $18. 00.
08Which pays a better dividend — M or DDS or KSS or BKE?
All stocks in this comparison pay dividends.
The Buckle, Inc. (BKE) offers the highest yield at 7. 3%, versus 3. 4% for Kohl's Corporation (KSS).
09Is M or DDS or KSS or BKE better for a retirement portfolio?
For long-horizon retirement investors, Dillard's, Inc.
(DDS) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 1. 15), 5. 6% yield, +918. 4% 10Y return). Kohl's Corporation (KSS) carries a higher beta of 2. 32 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (DDS: +918. 4%, KSS: -23. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between M and DDS and KSS and BKE?
Both stocks operate in the Consumer Cyclical sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.